PD L1 News and Research

RSS
Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Researchers find new way to prevent graft-versus-host disease after stem cell transplants

Researchers find new way to prevent graft-versus-host disease after stem cell transplants

Combination of anti-angiogenic and immune-stimulating therapies can lead to effective cancer treatments

Combination of anti-angiogenic and immune-stimulating therapies can lead to effective cancer treatments

ANGLE's Parsortix system shows high sensitivity, purity in gene expression analysis of head and neck cancers

ANGLE's Parsortix system shows high sensitivity, purity in gene expression analysis of head and neck cancers

Patients' immune system profiles could be linked to effectiveness of cancer immunotherapy

Patients' immune system profiles could be linked to effectiveness of cancer immunotherapy

Study explores new immunotherapy combinations to treat prostate cancer

Study explores new immunotherapy combinations to treat prostate cancer

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

FDA grants accelerated approval to new drug for treatment of rare form of skin cancer

Combination approach holds potential for treating lung cancer patients

Combination approach holds potential for treating lung cancer patients

New biomarker 'Bim' could help predict optimal treatment for metastatic melanoma patients

New biomarker 'Bim' could help predict optimal treatment for metastatic melanoma patients

Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

Combination of epigenetic and immune-based treatments could lead to better blood cancer therapies

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Melanoma patients' immunotherapy response linked to diversity and makeup of gut bacteria

Study paves way for therapies against myeloid-derived suppressor cells that collude with cancer

Study paves way for therapies against myeloid-derived suppressor cells that collude with cancer

New immunotherapy active against mucosal melanoma and improves survival for bladder cancer patients

New immunotherapy active against mucosal melanoma and improves survival for bladder cancer patients

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Inactive B2M genes can condition response of lung cancer patients to immunotherapy, study shows

Dual treatment strategies lengthen lives of mice with skin cancer

Dual treatment strategies lengthen lives of mice with skin cancer

New Forsyth study provides new foundation for fighting Sjögren's syndrome

New Forsyth study provides new foundation for fighting Sjögren's syndrome

PD-1 protein could serve as biomarker for predicting survival of lung cancer patients

PD-1 protein could serve as biomarker for predicting survival of lung cancer patients

Study suggests new approach to treat white blood cells of sepsis patients

Study suggests new approach to treat white blood cells of sepsis patients

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Researchers focus on optimal use of immune agents in frontline setting for NSCLC treatment

Researchers focus on optimal use of immune agents in frontline setting for NSCLC treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.